Korro Bio (KRRO) Depreciation & Amortization (CF) (2018 - 2026)

Korro Bio (KRRO) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $400000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 67.35% year-over-year to $400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 16.39% YoY) and the FY2025 annual result came in at $4.3 million, up 18.89% from the prior year.
• Depreciation & Amortization (CF) fell to $400000.0 in Q1 2026, from $649000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.3 million in Q4 2024 to a low of $385000.0 in Q3 2023.
• A 5-year average of $791647.1 and a median of $700000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 136.21% — and 2026, when it sank 67.35%.
• Tracing KRRO's Depreciation & Amortization (CF) over 5 years: stood at $417000.0 in 2022, then surged by 136.21% to $985000.0 in 2023, then jumped by 31.98% to $1.3 million in 2024, then tumbled by 50.08% to $649000.0 in 2025, then slumped by 38.37% to $400000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $400000.0 (Q1 2026), $649000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.